Insiders · Profile

Skvarka Jan

Director at Zentalis Pharmaceuticals. Filing since 11 Sep 2023. CIK 0001838042

Company

Date

Role

Action

Amount

Of holding

31 Jan 2025

Director

Bought

60,000

$103.45K

67.0%

11 Sep 2023

Director

Sold on a plan

5,000

$125.24K

9.4%

2 decisions on file.